First decisions about add-on reimbursement by CNEDiMTS at French National Authority for Health (HAS) from the meeting in April 2017

17

May 2017

At the meeting of 18th of April National Commission for Evaluation of Medical Devices and Health Technologies made decisions about add-on reimbursement of 17 medical devices. Ten decisions have been released to date for orthopedic, osteointegrated processing, cardiac and intravascular devices:

Decisions are pending about the following technologies:

  • ULTIMASTER, coronary endoprosthesis with sirolimus (renewal of condition for registration)
  • MAGNEZIX CS, bioresorbable screw for osteosynthesis (application for registration)
  • ESSURE, Intrafallopian implant - device for hysteroscopic tubal sterilization (5260 and DM_EVAL-143) (renewal of registration)
  • PENUMBRA 3D, thrombus reuptake system (retriever) (5251), PENUMBRA PACKAGE SYSTEM, Thrombus aspiration kit (ACE60 and ACE68) (5235) (application for registration)
  • MELODY with percutaneous implant system ASSEMBLY, percutaneous ultrasonic valve with implantation system (5264) (renewal of registration)
  • MELODY with percutaneous implant system ASSEMBLE II, Percutaneous pulmonary valve with implantation system (5223) (application for registration)
  • RESORB X (range) and SONICPINS RX, Resorbable plates and rivets for craniofacial osteosynthesis (5255) (application for registration)

Publications of opinions for these technologies are awaiting.

The agenda of the meeting in April can be seen in French here.

Subscribe to our biweekly newsletter not to miss important reimbursement information.

The latest related news

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more

03

Mar 2022

In February 2022, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, thirty health apps are now available at the DiGA Directory.

Read more